SB-221,284 je antagonist 5-HT2C receptora.[3]

SB-221,284
Nazivi
Preferisani IUPAC naziv
5-metilsulfanil-N-piridin-3-il-6-(trifluorometil)-2,3-dihidroindol-1-karboksamid
Drugi nazivi
CHEMBL276140 • 5-(metiltio)-1-(3-piridilkarbamoil)-6-(trifluorometil)indolin • SB 221284 • SB-221284 • SB 221284 • 196965-14-7 • SB-221284 • SB221284 • Tocris-1379 • CHEBI:8978 • GTPL191 • SCHEMBL8431394 • DTXSID50332080 • HMS3267D08 • HMS3412K08 • HMS3676K08 • BDBM50060418 • AKOS024456561 • SB64057 • NCGC00025133-01 • NCGC00025133-02 • HY-103155 • CS-0024686 • FT-0643837 • L000894 • SR-01000597580 • J-012734 • SR-01000597580-1 • BRD-K14807180-001-01-7 • Q27088709
Identifikacija
3D model (Jmol)
  • CSC1=C(C=C2C(=C1)CCN2C(=O)NC3=CN=CC=C3)C(F)(F)F
Svojstva
C16H14F3N3O2S
Molarna masa 369,36 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ Eric P M Prinssen; Francis C Colpaert; Wouter Koek (2002-10-25). „5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy”. Eur J Pharmacol. 453 (2-3): 217—21. doi:10.1016/s0014-2999(02)02430-5.